La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Keywords » - entrée « Parkinson Disease (drug therapy) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Parkinson Disease (diet therapy) < Parkinson Disease (drug therapy) < Parkinson Disease (economics)  Facettes :

List of bibliographic references indexed by Parkinson Disease (drug therapy)

Number of relevant bibliographic references: 464.
[20-40] [0 - 20][0 - 50][40-60]
Ident.Authors (with country if any)Title
000476 (2015) Kaylena A. Ehgoetz Martens [Canada] ; Colin G. Ellard [Canada] ; Quincy J. Almeida [Canada]Virtually-induced threat in Parkinson's: Dopaminergic interactions between anxiety and sensory-perceptual processing while walking.
000483 (2015) James A. G. Crispo [États-Unis] ; Yannick Fortin ; Dylan P. Thibault [États-Unis] ; Matthew Emons [États-Unis] ; Lise M. Bjerre ; Dafna E. Kohen ; Santiago Perez-Lloret [Argentine] ; Donald Mattison ; Allison W. Willis [États-Unis] ; Daniel KrewskiTrends in inpatient antiparkinson drug use in the USA, 2001–2012
000488 (2015) Janelle Drouin-Ouellet ; Isabelle St-Amour ; Martine Saint-Pierre ; Jérôme Lamontagne-Proulx ; Jasna Kriz ; Roger A. Barker ; Francesca CicchettiToll-Like Receptor Expression in the Blood and Brain of Patients and a Mouse Model of Parkinson’s Disease
000505 (2015) Matt J N. Brown [Canada] ; Quincy J. Almeida ; Fariborz RahimiThe dopaminergic system in upper limb motor blocks (ULMB) investigated during bimanual coordination in Parkinson's disease (PD).
000524 (2015) Paolo Solla [Italie] ; Alfonso Fasano [Canada] ; Antonino Cannas [Italie] ; Francesco Marrosu [Italie]Suicide and dopamine agonist withdrawal syndrome in Parkinson's disease.
000527 (2015) Fariborz Rahimi [Canada] ; Carina Bee [Irlande (pays)] ; David Wang [Canada] ; Farrokh Janabi-Sharifi [Canada] ; Quincy J. Almeida [Canada]Subgroup analysis of PD tremor with loading: action tremor as a combination of classical rest and physiological tremor.
000538 (2015) Emma D. Deeks [Oman]Safinamide: first global approval.
000542 (2015) Tanja Tran [Canada] ; James M. Brophy [Canada] ; Samy Suissa [Canada] ; Christel Renoux [Canada]Risks of Cardiac Valve Regurgitation and Heart Failure Associated with Ergot- and Non-Ergot-Derived Dopamine Agonist Use in Patients with Parkinson's Disease: A Systematic Review of Observational Studies.
000568 (2015) Constant V. M. Verschuur [Pays-Bas] ; S. R. Suwijn [Pays-Bas] ; B. Post [Pays-Bas] ; M. Dijkgraaf [Pays-Bas] ; B. R. Bloem [Pays-Bas] ; J. J. Van Hilten [Pays-Bas] ; T. Van Laar [Pays-Bas] ; G. Tissingh [Pays-Bas] ; G. Deuschl [Allemagne] ; A. E. Lang [Canada] ; R. J. De Haan [Pays-Bas] ; R. M. A. De Bie [Pays-Bas]Protocol of a randomised delayed-start double-blind placebo-controlled multi-centre trial for Levodopa in EArly Parkinson’s disease: the LEAP-study
000581 (2015) Alberto J. Espay ; Matthew M. Norris ; James C. Eliassen ; Alok Dwivedi ; Matthew S. Smith ; Christi Banks ; Jane B. Allendorfer ; Anthony E. Lang ; David E. Fleck ; Michael J. Linke ; Jerzy P. SzaflarskiPlacebo effect of medication cost in Parkinson disease
000592 (2015) Matthieu F. Bastide [France] ; Wassilios G. Meissner [France] ; Barbara Picconi [Italie] ; Stefania Fasano [Italie] ; Pierre-Olivier Fernagut [France] ; Michael Feyder [Suède] ; Veronica Francardo [Suède] ; Cristina Alcacer [Suède] ; Yunmin Ding [États-Unis] ; Riccardo Brambilla [Italie] ; Gilberto Fisone [Suède] ; A. Jon Stoessl [Canada] ; Mathieu Bourdenx [France] ; Michel Engeln [France] ; Sylvia Navailles [France] ; Philippe De Deurwaerdère [France] ; Wai Kin D. Ko [France] ; Nicola Simola [Italie] ; Micaela Morelli [Italie] ; Laurent Groc [France] ; Maria-Cruz Rodriguez [Espagne] ; Eugenia V. Gurevich [États-Unis] ; Maryka Quik [États-Unis] ; Michele Morari [Italie] ; Manuela Mellone [Italie] ; Fabrizio Gardoni [Italie] ; Elisabetta Tronci [Italie] ; Dominique Guehl [France] ; François Tison [France] ; Alan R. Crossman [Royaume-Uni] ; Un Jung Kang [Suède] ; Kathy Steece-Collier [États-Unis] ; Susan Fox [Canada] ; Manolo Carta [Italie] ; M. Angela Cenci [Suède] ; Erwan Bézard [Royaume-Uni]Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease.
000597 (2015) Brian J. Lithgow [Canada] ; Mehrnaz Shoushtarian [Oman]Parkinson's disease: disturbed vestibular function and levodopa.
000601 (2015) Philip Seeman [Canada]Parkinson's disease treatment may cause impulse-control disorder via dopamine D3 receptors.
000618 (2015) Simon YoungObituary of Theodore L. Sourkes, PhD, FRSC, OC
000642 (2015) I. Aracil-Bola Os [Canada] ; A. P. Strafella [Canada]Molecular imaging and neural networks in impulse control disorders in Parkinson’s disease
000674 (2015) Anthony E. Lang ; Ramon L. Rodriguez ; James T. Boyd ; Sylvain Chouinard ; Cindy Zadikoff ; Alberto J. Espay ; John T. Slevin ; Hubert H. Fernandez ; Mark F. Lew ; David A. Stein ; Per Odin ; Victor S. C. Fung ; Fabian Klostermann ; Alfonso Fasano ; Peter V. Draganov ; Nathan Schmulewitz ; Weining Z. Robieson ; Susan Eaton ; Krai Chatamra ; Janet A. Benesh ; Jordan DubowIntegrated safety of levodopa‐carbidopa intestinal gel from prospective clinical trials
000676 (2015) Alfonso Fasano [Canada] ; Louis W C. Liu ; Yu-Yan Poon ; Antony E. LangInitiating intrajejunal infusion of levodopa/carbidopa intestinal gel: an outpatient model.
000683 (2015) Pierre J. Blanchet [Canada] ; Emmanuelle PourcherIn memoriam: Paul J. Bédard, MD PhD: January 19, 1942-December 26, 2014.
000687 (2015) David Mongeon [Canada] ; Pierre Blanchet ; Stéphanie Bergeron ; Julie MessierImpact of Parkinson's disease on proprioceptively based on-line movement control.
000689 (2015) Clive Ballard [Royaume-Uni] ; Stuart Isaacson [États-Unis] ; Roger Mills [États-Unis] ; Hilde Williams [États-Unis] ; Anne Corbett [Royaume-Uni] ; Bruce Coate [États-Unis] ; Rajesh Pahwa [États-Unis] ; Olivier Rascol [France] ; David J. Burn [Royaume-Uni]Impact of Current Antipsychotic Medications on Comparative Mortality and Adverse Events in People With Parkinson Disease Psychosis.
000718 (2015) Alfonso Fasano [Canada] ; Naomi P. Visanji [Canada] ; Louis W C. Liu [Canada] ; Antony E. Lang [Canada] ; Ronald F. Pfeiffer [États-Unis]Gastrointestinal dysfunction in Parkinson's disease.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Parkinson Disease (drug therapy)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Parkinson Disease (drug therapy)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Parkinson Disease (drug therapy)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022